Rocket Lab posts $268 million quarter, expects Neutron in 2027
Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, exceeding forecasts. Net loss widened to $79.7M, with adjusted EBITDA at -$18.0M. Space systems revenue grew 88% to $214.8M. Neutron rocket's launch delayed to 2027 due to manufacturing issues. Backlog reached $3.57B, with $1B in new launch contracts. Iridium acquisition pending regulatory approval, expected to close in 2027.
How this was made
The 30-second read
Why it matters
The earnings beat may attract buying interest, but the loss expansion and product delay could offset gains, leading to a muted or slightly negative market reaction.
Market read
First-report earnings for a mid-cap space launch firm with material financial figures and operational updates, relevant for aerospace sector investors.
What to watch
The $1B of new launch contracts and a $515M Neutron contract backlog may provide longer-term upside not reflected in immediate price action.
Background
Rocket Lab's Q3 filing includes a higher-than-expected revenue number, a widened loss, and a delay of its flagship Neutron rocket to 2027 due to a tank issue.
Ticker impact
Rocket Lab reported Q3 2026 revenue of $267.8M, a 73% YoY increase, but net loss widened to $79.7M and Neutron launch delayed to 2027.
likely modest downside as investors digest higher loss and launch delay
Revenue topped guidance, yet widening loss and a key product delay introduce uncertainty, balancing the reaction.
Market effects
Space launch sector may see mixed sentiment; revenue growth supports demand, but Neutron delay could temper optimism.
U.S. small-cap aerospace stocks could experience slight pressure.
Limited to investors focused on commercial space and satellite services.
Counterpoint
Despite the loss widening, the strong order backlog and revenue beat could justify a short-term rally.
Key entities
- companyRocket Lab
U.S.-listed aerospace launch provider (NASDAQ: RKLB).


